October 24, 2016 9:33 AM ET


Company Overview of Cerulean Pharma Inc.

Executive Profile

Alan L. Crane M.A., M.B.A.

Co-Founder and Director, Cerulean Pharma Inc.
AgeTotal Calculated CompensationThis person is connected to 7 Board Members in 7 different organizations across 17 different industries.

See Board Relationships


Mr. Alan L. Crane, M.A., M.B.A. is a Co-Founder, Chairman, and President at Arsia Therapeutics, Inc. Mr. Crane is an Advisor at The Experiment Fund. Mr. Crane is a Partner and Entrepreneur at Polaris Partners and is part of Healthcare team. He focuses on building and investing in healthcare companies. He serves as the President and Chief Executive Officer of Tempo Pharmaceuticals, Inc. He is the Founder, Chairman and Chief Executive Officer of Navitor Pharmaceuticals, ...

Corporate Headquarters

35 Gatehouse Drive
Waltham, Massachusetts 02451

United States

Phone: 781-996-4300
Fax: --

Board Members Memberships

Founder, Chairman of The Board, Chairman of Compensation Committee and Member of Audit Committee
Founder and Chairman of the Board
Co-Founder, President, and Chairman
Co-Founder and Director


Harvard College
MBA 1992
Harvard Business School
MD 1988
Harvard Medical School
MA 1986
Harvard Graduate School Of Arts And Sciences

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$32,500
Total Calculated Compensation$61,036

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Cerulean Pharma Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.